NOVOGEN Limited has sold its
consumer products business to
Pharma-A-Care Laboratories P/L,
for a total price of $10.1m.
Chairman William Rueckert said
the move followed a strategic
review, with consumer products
considered “non-core to the
company’s future focus on drug
development”.
He said most of the proceeds
would be invested in Novogen’s
majority-owned subsidiaries
Marshall Edwards and GlycotexThe above article was sent to subscribers in Pharmacy Daily's issue from 03 Aug 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Aug 11
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.